MARA Holdings
MARA
MicroStrategy
MSTR
Tesla
TSLA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
QTTB Q32 Bio
- 3.910
- +0.460+13.33%
Close Jan 3 16:00 ET
- 3.879
- -0.031-0.80%
Post 20:01 ET
47.63MMarket Cap-0.30P/E (TTM)
4.000High3.260Low740.82KVolume3.440Open3.450Pre Close2.76MTurnover14.54%Turnover RatioLossP/E (Static)12.18MShares53.79052wk High2.60P/B19.92MFloat Cap3.02052wk Low--Dividend TTM5.09MShs Float546.837Historical High--Div YieldTTM21.45%Amplitude3.020Historical Low3.729Avg Price1Lot Size
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Q32 Bio Stock Forum
Worse than placebo for Eczema, ouch
Alopecia worked well, but probably people were looking for the eczema market?
Sorry I am sleepy cant finish the list.
$Rigetti Computing (RGTI.US)$ PR today 12/10: Quantum Machines And Rigetti Computing Announces The Application Of AI To Automate The Calibration Of A Quantum Computer. Up after hours. SI 13.89%, 0 shares LTB✅
$SEALSQ Corp (LAES.US)$ PR 12/10: Partnership with IC’ALPS to ...
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday, 10th December at 4:05 pm
-- SIGNAL-AA demonstrated encouraging clinical activity of bempikibart in patients with alopecia areata (AA), including improvement from baseline on SALT score and meaningful achievement of SALT-20 response --
-- SIGNAL-AD Phase 2a clinical trial in atopic dermatitis demonstrated promising findings in Part A but did not meet ...
$Trio Petroleum (TPET.US)$ buy
No comment yet